GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genedrive PLC (LSE:GDR) » Definitions » Ending Cash Position

Genedrive (LSE:GDR) Ending Cash Position : £1.23 Mil (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Genedrive Ending Cash Position?

Genedrive's Ending Cash Position for the quarter that ended in Dec. 2023 was £1.23 Mil.

Genedrive's quarterly Ending Cash Position increased from Dec. 2022 (£2.08 Mil) to Jun. 2023 (£2.60 Mil) but then declined from Jun. 2023 (£2.60 Mil) to Dec. 2023 (£1.23 Mil).

Genedrive's annual Ending Cash Position increased from Jun. 2021 (£2.57 Mil) to Jun. 2022 (£4.59 Mil) but then declined from Jun. 2022 (£4.59 Mil) to Jun. 2023 (£2.60 Mil).


Genedrive Ending Cash Position Historical Data

The historical data trend for Genedrive's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genedrive Ending Cash Position Chart

Genedrive Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.18 8.22 2.57 4.59 2.60

Genedrive Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.30 4.59 2.08 2.60 1.23

Genedrive Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Genedrive's Ending Cash Position for the fiscal year that ended in Jun. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=4.589+-1.988
=2.60

Genedrive's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=2.601+-1.375
=1.23


Genedrive Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Genedrive's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Genedrive (LSE:GDR) Business Description

Traded in Other Exchanges
Address
48 Grafton Street, The Incubator Building, Manchester, GBR, M13 9XX
Genedrive PLC is a holding company engaged in the molecular diagnostics business. It operates in one operating segment named Diagnostics which is engaged in the Genedrive Point of need molecular diagnostics platform for the diagnosis of infectious diseases and use in patient stratification (genotyping), pathogen detection, and other indications. Geographically the majority of the revenue is derived from the United Kingdom.

Genedrive (LSE:GDR) Headlines

No Headlines